IHM
Iguana Healthcare Management Portfolio holdings
AUM
$133M
This Quarter Return
+23.92%
1 Year Return
+45.66%
3 Year Return
+127.07%
5 Year Return
–
10 Year Return
–
AUM
$238M
AUM Growth
+$238M
(+31%)
Cap. Flow
+$39M
Cap. Flow
% of AUM
16.39%
Top 10 Holdings %
Top 10 Hldgs %
44.18%
Holding
82
New
31
Increased
11
Reduced
13
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$18.3M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$7.76M |
| 3 |
AGN
Allergan plc
AGN
|
$7.44M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$6.22M |
| 5 |
ENDP
Endo International plc
ENDP
|
$5.38M |
Top Sells
| 1 |
Biogen
BIIB
|
$13.6M |
| 2 |
Medtronic
MDT
|
$9.03M |
| 3 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
$6.13M |
| 4 |
Viatris
VTRS
|
$5.64M |
| 5 |
Amgen
AMGN
|
$5.58M |
Sector Composition
| 1 | Healthcare | 81.93% |
| 2 | Real Estate | 0.91% |
| 3 | Technology | 0.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVDQ
26
DELISTED
Novadaq Technologies Inc.
NVDQ
| $3.25M | 1.37% |
200,000
+25,000
| +14% | +$406K |
|
|
MDVN
27
DELISTED
MEDIVATION, INC.
MDVN
| $3.23M | 1.36% |
+25,000
| New | +$3.23M |
|
|
PETX
28
DELISTED
Aratana Therapeutics, Inc.
PETX
| $3.2M | 1.35% |
200,000
+20,000
| +11% | +$320K |
|
29
Elevance Health
ELV
$71.8B
| $3.09M | 1.3% |
+20,000
| New | +$3.09M |
|
30
Merck
MRK
$210B
| $2.87M | 1.21% |
50,000
-25,000
| -33% | -$1.44M |
|
31
Celldex Therapeutics
CLDX
$1.47B
| $2.79M | 1.17% |
100,000
| – | – |
|
|
TTPH
32
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $2.75M | 1.16% |
+75,000
| New | +$2.75M |
|
33
Ligand Pharmaceuticals
LGND
$3.15B
| $2.7M | 1.14% |
+35,000
| New | +$2.7M |
|
|
WMGI
34
DELISTED
Wright Medical Group Inc
WMGI
| $2.58M | 1.09% |
100,000
-15,000
| -13% | -$387K |
|
|
DYAX
35
DELISTED
DYAX CORPORATION
DYAX
| $2.51M | 1.06% |
150,000
-25,000
| -14% | -$419K |
|
36
AbbVie
ABBV
$372B
| $2.32M | 0.97% |
50,000
-25,000
| -33% | -$1.16M |
|
37
Abbott
ABT
$231B
| $2.32M | 0.97% |
+50,000
| New | +$2.32M |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.43B
| $2.25M | 0.95% |
+125,000
| New | +$2.25M |
|
39
Healthpeak Properties
DOC
$12.5B
| $2.16M | 0.91% |
+50,000
| New | +$2.16M |
|
|
IMDZ
40
DELISTED
Immune Design Corp.
IMDZ
| $2.11M | 0.89% |
+100,000
| New | +$2.11M |
|
41
Assembly Biosciences
ASMB
$190M
| $1.99M | 0.84% |
150,000
+100,000
| +200% | +$1.32M |
|
42
Neurocrine Biosciences
NBIX
$13.8B
| $1.99M | 0.84% |
+50,000
| New | +$1.99M |
|
|
SPNC
43
DELISTED
Spectranetics Corp
SPNC
| $1.74M | 0.73% |
50,000
| – | – |
|
|
IPCM
44
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
| $1.63M | 0.69% |
+35,000
| New | +$1.63M |
|
|
CSLT
45
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $1.55M | 0.65% |
+200,000
| New | +$1.55M |
|
46
PTC Therapeutics
PTCT
$3.92B
| $1.52M | 0.64% |
+25,000
| New | +$1.52M |
|
|
ETRM
47
DELISTED
EnteroMedics Inc.
ETRM
| $1.32M | 0.56% |
1,444,000
-1,000,000
| -41% | -$915K |
|
|
DERM
48
DELISTED
Dermira, Inc.
DERM
| $1.23M | 0.52% |
80,000
+30,000
| +60% | +$461K |
|
49
TherapeuticsMD
TXMD
$12.8M
| $1.21M | 0.51% |
+200,000
| New | +$1.21M |
|
|
KND
50
DELISTED
Kindred Healthcare
KND
| $1.19M | 0.5% |
+50,000
| New | +$1.19M |
|